15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 23 firms covering DexCom Inc, 20 rate it Buy or better, 2 sit at Hold, and 1 rate it Sell or worse, a strong buy consensus. Targets span $64.00 to $95.00, a moderate spread. The average target of $84.60 sits 13% above the current $74.84. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.67 next quarter toward $3.08 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS23 ratings
Strong Buy
Strong Buy14%
Buy1983%
Hold29%
Sell14%
Strong Sell00%
Based on 23 analysts giving stock ratings to DexCom Inc.
As of Jul, 18 of 21 firms rate DXCM a Buy (2 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
DXCM EPS & revenue forecast
EPS · NEXT QUARTER
$0.67
Range $0.62 – $0.69 · 19 analysts · +10% YoY
Next period, 19 analysts expect DexCom Inc to earn $0.67 a share (range $0.62 – $0.69), versus $0.61 a year earlier. Full-year consensus is $2.59, growing to $3.08 the year after.
REVENUE · NEXT QUARTER
$1.3B
Range $1.3B – $1.4B · 19 analysts · +10% YoY
Revenue is expected to reach $1.3B (range $1.3B – $1.4B), +10.4% year-over-year. Full-year consensus is $5.2B, rising to $5.8B next year.
Top analysts covering DexCom Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DXCM.
#1
Jonathan Block
Stifel · Rank #172
Buy
$90.00+20.3% to target
Overall win rate
42%
+ Follow
#2
William Plovanic
Canaccord Genuity · Rank #190
Buy
$82.00+9.6% to target
Overall win rate
36%
+ Follow
#3
Bruce Jackson
Benchmark · Rank #317
Buy
$77.00+2.9% to target
Overall win rate
35%
+ Follow
#4
Matt O'Brien
Piper Sandler · Rank #356
Buy
$88.00+17.6% to target
Overall win rate
25%
+ Follow
#5
Joanne Wuensch
Citigroup
Buy
$84.00+12.2% to target
Coverage
—
+ Follow
DXCM stock forecast FAQ
What is DXCM's average 12-month price target?+
The 10 analysts with a live target average $84.60 for DexCom Inc over the next 12 months, ranging from a $95.00 high to a $64.00 low.
Is DXCM stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 23 analyst ratings, 20 are Buy or Strong Buy, 2 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for DXCM?+
The Street-high target is $95.00 (TD Cowen), and the Street-low is $64.00 (Barclays). The average of all 10 active targets is $84.60.
How many Wall Street analysts cover DXCM?+
23 analysts have an active rating on DexCom Inc, and 10 firms carry a live 12-month price target.
Who is the most accurate analyst covering DXCM?+
Among analysts who currently cover DXCM, Jonathan Block of Stifel has the strongest overall Quantellect track record (Rank #172). Their current call is Buy with a $90.00 target.
What is DexCom Inc's projected EPS for next quarter?+
The consensus estimate is $0.67 per share (range $0.62 – $0.69) across 19 analysts. Full-year EPS is projected at $2.59, rising to $3.08 the following year.
How much revenue is DexCom Inc expected to report next quarter?+
Consensus revenue is $1.3B (range $1.3B – $1.4B). Full-year revenue is projected at $5.2B, growing to $5.8B next year.
Have analysts been upgrading or downgrading DXCM lately?+
As of Jul, 18 of 21 firms rate DXCM a Buy (2 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DXCM calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
Deutsche Bank
